Prota Therapeutics releases data from four year immunotherapy study with outstanding results

21 August 2017

You may also like

23 May 2018

Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003)

18 April 2018

Prota Therapeutics partners with world leading bioscience company, Chr. Hansen

27 May 2017

OneVentures makes first investment for the Biomedical Translation Fund

07 April 2017

Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy

View All

Ventured. Gained.

Subscribe to our Newsletter.

Name
This field is for validation purposes and should be left unchanged.
decor